Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07MON
|
||||
Former ID |
DNC003727
|
||||
Drug Name |
ONAPRISTONE
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C29H39NO3
|
||||
InChI |
InChI=1S/C29H39NO3/c1-28-18-25(19-5-8-21(9-6-19)30(2)3)27-23-12-10-22(32)17-20(23)7-11-24(27)26(28)13-15-29(28,33)14-4-16-31/h5-6,8-9,17,24-26,31,33H,4,7,10-16,18H2,1-3H3/t24-,25+,26-,28+,29+/m0/s1
|
||||
InChIKey |
IEXUMDBQLIVNHZ-YOUGDJEHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | Modulator | ||
KEGG Pathway | Oocyte meiosis | ||||
Progesterone-mediated oocyte maturation | |||||
Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
References | |||||
Ref 524622 | ClinicalTrials.gov (NCT02049190) Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer. U.S. National Institutes of Health. | ||||
Ref 539909 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2882). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.